Tehreen Parveen: Historical Milestone in Drug Discovery – The Discovery of Aspirin
Tehreen Parveen, Assistant Professor at RIMT University, shared a post on LinkedIn:
“Historical Milestone in Drug Discovery: The Discovery of Aspirin
Few medicines have had as profound an impact on global healthcare as aspirin.
What began as a traditional remedy derived from willow bark evolved into one of the most widely used and studied drugs in medical history. In 1897, chemist Felix Hoffmann developed a more stable and tolerable form of acetylsalicylic acid, paving the way for the medicine we know today as aspirin.
Why Aspirin Changed Medicine
- Revolutionized pain and fever management
- Became a cornerstone treatment for inflammation
- Opened new avenues in medicinal chemistry
- Continues to play a vital role in cardiovascular disease prevention
- Demonstrated how natural products can inspire transformative medicines
A Journey Through Time
- Ancient civilizations used willow bark to relieve pain and fever.
- 1828 – Salicin, the active compound, was isolated from willow bark.
- 1853 – Salicylic acid was synthesized, though it often caused stomach irritation.
- 1897 – Felix Hoffmann developed acetylsalicylic acid, creating a safer and more effective compound.
- 1899 – Aspirin was introduced commercially and went on to become one of the world’s most trusted medicines.
More than a century later, aspirin remains a powerful example of how scientific innovation can transform traditional knowledge into a medicine that improves millions of lives.
From willow bark to modern medicine, aspirin’s story is a testament to the enduring impact of drug discovery.”

Stay updated with Hemostasis Today.
-
Sep 29, 2026, 03:53Nahrwan Masaoodi: Iron Deficiency Can Exist Without Anemia
-
Sep 29, 2026, 03:38Muhammad Yousaf: Iron Deficiency Beyond Diet
-
Sep 29, 2026, 03:21Parvez Ahmed Chowdhury: Synthesizing Aspirin in the Organic Chemistry Lab
-
Sep 29, 2026, 03:12Ahmed Hamandi: Building the Future of Hematopoietic Transplantation in Iraq
-
Sep 29, 2026, 03:09M V Chandrakanth: Aspirin in CRC – Old Drug, New Precision Oncology?
-
Sep 29, 2026, 03:07Caroline Pothet: Advancing Treatment Development in Sickle Cell Disease and Thalassaemia
-
Sep 29, 2026, 02:53Astha Jain: Thalassemia Care Through a Public Health Lens
-
Sep 29, 2026, 02:50Emma Groarke: Starting a New Career Path in Homeland
-
Sep 28, 2026, 19:14Aditya Sharma: An Outstanding Start to the Final Day of VSS 2026!